Open access
Aug 2026
Targeting IDH-driven Oncometabolism in glioblastoma: a computational approach for the identification of potential inhibitors
I1Hit1 and I2Hit1 are highlighted as novel therapeutic compounds with efficient IDH-target inhibition to address epigenetic modification in GBM, and further experimental validation of these compounds is required to demonstrate potential inhibitors of IDH-driven metabolism in GBM.
Nivedhitha Tamilazhagan, S. Arumugam
· Frontiers in Bioinformatics · 0 citations